vs

Side-by-side financial comparison of ALT5 Sigma Corp (ALTS) and COMPUGEN LTD (CGEN). Click either name above to swap in a different company.

ALT5 Sigma Corp is the larger business by last-quarter revenue ($5.4M vs $3.5M, roughly 1.5× COMPUGEN LTD). COMPUGEN LTD runs the higher net margin — -410.1% vs -7100.2%, a 6690.0% gap on every dollar of revenue. On growth, ALT5 Sigma Corp posted the faster year-over-year revenue change (12.5% vs -61.8%). ALT5 Sigma Corp produced more free cash flow last quarter ($-7.2M vs $-18.8M).

ALT5 Sigma Corp is a fintech firm focused on digital asset infrastructure and trading solutions. It operates regulated digital asset trading platforms for retail and institutional clients, primarily serving markets across North America, Europe, and the Asia-Pacific region. Its core offerings include spot and derivatives trading, digital asset custody, and secure settlement services.

Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big compan...

ALTS vs CGEN — Head-to-Head

Bigger by revenue
ALTS
ALTS
1.5× larger
ALTS
$5.4M
$3.5M
CGEN
Growing faster (revenue YoY)
ALTS
ALTS
+74.2% gap
ALTS
12.5%
-61.8%
CGEN
Higher net margin
CGEN
CGEN
6690.0% more per $
CGEN
-410.1%
-7100.2%
ALTS
More free cash flow
ALTS
ALTS
$11.6M more FCF
ALTS
$-7.2M
$-18.8M
CGEN

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
ALTS
ALTS
CGEN
CGEN
Revenue
$5.4M
$3.5M
Net Profit
$-381.5M
$-14.5M
Gross Margin
40.9%
Operating Margin
-38.1%
-475.1%
Net Margin
-7100.2%
-410.1%
Revenue YoY
12.5%
-61.8%
Net Profit YoY
-7249.1%
-54.7%
EPS (diluted)
$-5.53
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALTS
ALTS
CGEN
CGEN
Q4 25
$5.4M
Q3 25
$7.6M
Q2 25
$6.4M
$3.5M
Q1 25
$5.5M
Q4 24
$4.8M
Q3 24
$4.9M
Q2 24
$2.2M
$9.3M
Q1 24
$0
$2.6M
Net Profit
ALTS
ALTS
CGEN
CGEN
Q4 25
$-381.5M
Q3 25
$49.0M
Q2 25
$-9.1M
$-14.5M
Q1 25
$-2.9M
Q4 24
$-5.2M
Q3 24
$-822.0K
Q2 24
$589.0K
$-9.4M
Q1 24
$-2.1M
$7.3M
Gross Margin
ALTS
ALTS
CGEN
CGEN
Q4 25
40.9%
Q3 25
34.6%
Q2 25
43.5%
Q1 25
47.0%
Q4 24
45.8%
Q3 24
47.8%
Q2 24
50.6%
60.5%
Q1 24
17.9%
Operating Margin
ALTS
ALTS
CGEN
CGEN
Q4 25
-38.1%
Q3 25
-218.3%
Q2 25
-32.8%
-475.1%
Q1 25
-39.4%
Q4 24
-40.8%
Q3 24
-14.8%
Q2 24
-112.2%
-128.5%
Q1 24
Net Margin
ALTS
ALTS
CGEN
CGEN
Q4 25
-7100.2%
Q3 25
646.4%
Q2 25
-142.9%
-410.1%
Q1 25
-51.9%
Q4 24
-108.7%
Q3 24
-16.6%
Q2 24
27.2%
-101.4%
Q1 24
284.0%
EPS (diluted)
ALTS
ALTS
CGEN
CGEN
Q4 25
$-5.53
Q3 25
$0.29
Q2 25
$-0.49
$-0.16
Q1 25
$-0.18
Q4 24
$-0.35
Q3 24
$-0.06
Q2 24
$0.07
$-0.10
Q1 24
$-0.34
$89505618.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALTS
ALTS
CGEN
CGEN
Cash + ST InvestmentsLiquidity on hand
$6.2M
$35.3M
Total DebtLower is stronger
$563.0K
Stockholders' EquityBook value
$1.2B
$50.3M
Total Assets
$1.2B
$106.5M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALTS
ALTS
CGEN
CGEN
Q4 25
$6.2M
Q3 25
$7.3M
Q2 25
$9.6M
$35.3M
Q1 25
$10.8M
Q4 24
$7.2M
Q3 24
$8.7M
Q2 24
$5.8M
$44.6M
Q1 24
$61.0K
$39.3M
Total Debt
ALTS
ALTS
CGEN
CGEN
Q4 25
$563.0K
Q3 25
Q2 25
Q1 25
Q4 24
$563.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ALTS
ALTS
CGEN
CGEN
Q4 25
$1.2B
Q3 25
$1.6B
Q2 25
$26.1M
$50.3M
Q1 25
$21.8M
Q4 24
$12.4M
Q3 24
$20.2M
Q2 24
$22.9M
$58.3M
Q1 24
$3.8M
$65.6M
Total Assets
ALTS
ALTS
CGEN
CGEN
Q4 25
$1.2B
Q3 25
$1.6B
Q2 25
$94.7M
$106.5M
Q1 25
$78.0M
Q4 24
$75.7M
Q3 24
$74.9M
Q2 24
$75.4M
$110.2M
Q1 24
$18.6M
$121.3M
Debt / Equity
ALTS
ALTS
CGEN
CGEN
Q4 25
0.00×
Q3 25
Q2 25
Q1 25
Q4 24
0.05×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALTS
ALTS
CGEN
CGEN
Operating Cash FlowLast quarter
$-7.2M
$-18.6M
Free Cash FlowOCF − Capex
$-7.2M
$-18.8M
FCF MarginFCF / Revenue
-133.4%
-530.8%
Capex IntensityCapex / Revenue
0.2%
6.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALTS
ALTS
CGEN
CGEN
Q4 25
$-7.2M
Q3 25
$-8.7M
Q2 25
$-5.2M
$-18.6M
Q1 25
$-1.5M
Q4 24
$1.8M
Q3 24
$4.2M
Q2 24
$80.0K
$39.7M
Q1 24
$-544.0K
Free Cash Flow
ALTS
ALTS
CGEN
CGEN
Q4 25
$-7.2M
Q3 25
Q2 25
$-18.8M
Q1 25
Q4 24
Q3 24
Q2 24
$39.7M
Q1 24
FCF Margin
ALTS
ALTS
CGEN
CGEN
Q4 25
-133.4%
Q3 25
Q2 25
-530.8%
Q1 25
Q4 24
Q3 24
Q2 24
428.3%
Q1 24
Capex Intensity
ALTS
ALTS
CGEN
CGEN
Q4 25
0.2%
Q3 25
Q2 25
6.5%
Q1 25
Q4 24
Q3 24
Q2 24
0.4%
Q1 24
Cash Conversion
ALTS
ALTS
CGEN
CGEN
Q4 25
Q3 25
-0.18×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.14×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons